Lunit is a leading provider of AI solutions for cancer diagnostics and therapeutics, with a mission to conquer cancer through AI.



Our clinically proven AI enables healthcare providers to detect cancer earlier, make more precise treatment decisions, and improve patient outcomes — transforming how cancer is diagnosed and treated.



Our technology spans the entire cancer continuum, from risk prediction and screening optimization to early detection and precision oncology.



Lunit’s breast and chest imaging AI boosts diagnostic accuracy and efficiency, while our pathology AI is leveraged by leading pharmaceutical companies to drive biomarker discovery and companion diagnostics (CDx) development.



Trusted by 10,000+ sites across 65+ countries,

Lunit continues to redefine global standards in data-driven cancer care.



Learn more about our technology and mission at www.lunit.io/en